ETF Managers Group, LLC Corbus Pharmaceuticals Holdings, Inc. Transaction History

ETF Managers Group, LLC

$2.78 Billion
Q1 2023

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.17 - $5.31 $399,868 - $12.5 Million	-2,352,166 Reduced 33.31%	4,710,319 $777,000
Q2 2022 Aug 15, 2022	SELL	$0.21 - $0.53 $894,708 - $2.26 Million	-4,260,515 Reduced 37.63%	7,062,485 $1.79 Million
Q1 2022 May 13, 2022	SELL	$0.32 - $0.67 $901,119 - $1.89 Million	-2,815,998 Reduced 19.92%	11,323,000 $5.8 Million
Q4 2021 Feb 14, 2022	BUY	$0.6 - $1.11 $22,492 - $41,610	37,487 Added 0.27%	14,138,998 $8.53 Million
Q3 2021 Nov 15, 2021	SELL	$1.01 - $1.82 $10,373 - $18,693	-10,271 Reduced 0.07%	14,101,511 $14.2 Million
Q2 2021 Aug 16, 2021	BUY	$1.39 - $2.21 $11.2 Million - $17.9 Million	8,091,387 Added 134.4%	14,111,782 $26 Million
Q1 2021 May 17, 2021	SELL	$1.27 - $3.42 $2.65 Million - $7.12 Million	-2,083,246 Reduced 25.71%	6,020,395 $11.9 Million
Q4 2020 Feb 16, 2021	BUY	$0.94 - $1.89 $4.19 Million - $8.42 Million	4,453,993 Added 122.04%	8,103,641 $10.1 Million
Q3 2020 Nov 16, 2020	SELL	$1.5 - $9.38 $87,396 - $546,516	-58,264 Reduced 1.57%	3,649,648 $6.57 Million
Q2 2020 Aug 14, 2020	BUY	$4.79 - $8.39 $668,525 - $1.17 Million	139,567 Added 3.91%	3,707,912 $31.1 Million
Q1 2020 May 14, 2020	SELL	$3.44 - $7.21 $7.61 Million - $15.9 Million	-2,211,297 Reduced 38.26%	3,568,345 $18.7 Million
Q4 2019 Feb 14, 2020	SELL	$4.29 - $5.64 $4.76 Million - $6.26 Million	-1,109,718 Reduced 16.11%	5,779,642 $31.6 Million
Q3 2019 Nov 14, 2019	SELL	$4.87 - $7.08 $592,635 - $861,572	-121,691 Reduced 1.74%	6,889,360 $33.6 Million
Q2 2019 Aug 14, 2019	BUY	$6.6 - $7.8 $46.3 Million - $54.7 Million	7,011,051 New	7,011,051 $48.6 Million
Q1 2019 May 07, 2019	SELL	$5.76 - $8.95 $22.8 Million - $35.4 Million	-3,958,561 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$5.26 - $7.97 $20.8 Million - $31.5 Million	3,958,561 New	3,958,561 $23.3 Million
Q3 2018 Nov 14, 2018	SELL	$4.65 - $7.95 $8.51 Million - $14.6 Million	-1,830,450 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$5.05 - $6.8 $3.16 Million - $4.26 Million	-626,471 Reduced 25.5%	1,830,450 $84,000
Q1 2018 May 15, 2018	BUY	$5.6 - $9.25 $12.5 Million - $20.6 Million	2,229,245 Added 979.13%	2,456,921 $14.5 Million
Q4 2017 Feb 14, 2018	BUY	$6.6 - $7.78 $1.5 Million - $1.77 Million	227,676	227,676 $1.81 Million

Others Institutions Holding CRBP

# of Institutions

Shares Held

38.7K

Call Options Held

Put Options Held

Kingsbury Capital Investment Advisors LLC Evanston, IL

33.7K
Shares

$329,249
0.01% of portfolio
Exane Derivatives

2.65K
Shares

$25,890
0.0% of portfolio
American Portfolios Advisors Holbrook, NY

2.31K
Shares

$22,588
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Corbus Pharmaceuticals Holdings, Inc.

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $1.22B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

More about CRBP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on ETF Managers Group, LLC with notifications on news.

Account